INKT
Mink Therapeutics
$10.59
−$0.48 (−4.34%)Jul 27, 2026
Key metrics
The numbers that frame INKT today
- Market cap
- $52.76M
- P/E (TTM)
- -4.2
- EV / FCF
- -6.8
- ROIC
- 182.8%
- Div yield
- 0%
- 52wk Low
- $8.48
- 52wk High
- $20.25
Growth
Revenue and earnings trend for INKT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about INKT
Is Mink Therapeutics a good buy?
No. Mink Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Mink Therapeutics is selling at a very high price.
What is the market capitalization of INKT?
Mink Therapeutics's market capitalization is $52.76M.
What is the P/E ratio for INKT stock?
Mink Therapeutics's current P/E ratio is -4.2.
What is the 52-week high for INKT stock?
The 52-week high for Mink Therapeutics is $20.25. The current close of $10.59 is 47.7% below that high.
What is the 52-week low for INKT stock?
The 52-week low for Mink Therapeutics is $8.48. The current close of $10.59 is 24.9% above that low.
Does INKT stock pay dividends?
Mink Therapeutics does not currently show a dividend per share in the company data.